Response Genetics Inc
Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gast… Read more
Response Genetics Inc (RGDXQ) - Total Liabilities
Latest total liabilities as of March 2015: $15.72 Million USD
Based on the latest financial reports, Response Genetics Inc (RGDXQ) has total liabilities worth $15.72 Million USD as of March 2015.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Response Genetics Inc - Total Liabilities Trend (2005–2015)
This chart illustrates how Response Genetics Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Response Genetics Inc Competitors by Total Liabilities
The table below lists competitors of Response Genetics Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LCTI Low Carbon Technologies International Inc
PINK:LWCTF
|
USA | $34.11 Million |
|
Universal Tracking Solutions Inc
PINK:UTRK
|
USA | $192.39K |
|
Fitvia Corp
PINK:BRZV
|
USA | $610.48K |
|
ZipLink Inc
PINK:ZIPL
|
USA | $24.91 Million |
|
Idglobal Corp
PINK:IDGC
|
USA | $1.60 Million |
|
Foodfest Intl 2000
PINK:FDFT
|
USA | $130.25K |
|
Buzz Technologies Inc
PINK:BZTG
|
USA | $933.83K |
|
International Card Establishment Inc
PINK:ICRD
|
USA | $1.15 Million |
Liability Composition Analysis (2005–2015)
This chart breaks down Response Genetics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -3.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Response Genetics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Response Genetics Inc (2005–2015)
The table below shows the annual total liabilities of Response Genetics Inc from 2005 to 2015.
| Year | Total Liabilities | Change |
|---|---|---|
| 2015-12-31 | $15.87 Million | +8.57% |
| 2014-12-31 | $14.62 Million | +18.83% |
| 2013-12-31 | $12.30 Million | -28.21% |
| 2012-12-31 | $17.13 Million | +22.47% |
| 2011-12-31 | $13.99 Million | +0.80% |
| 2010-12-31 | $13.88 Million | +36.80% |
| 2009-12-31 | $10.14 Million | +51.92% |
| 2008-12-31 | $6.68 Million | -28.27% |
| 2007-12-31 | $9.31 Million | -32.36% |
| 2006-12-31 | $13.76 Million | +86.48% |
| 2005-12-31 | $7.38 Million | -- |